TNX-103 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Pipeline

Phase 3: 1

Top Sponsors

Tenax Therapeutics, Inc.1

Indications

Pulmonary Hypertension Associated With HFpEF1
Heart Disease1

Alexander City, Alabama1 trial

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Tenax Investigational Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.